Strategic Plan
We are pleased to present the Australia and New Zealand Sarcoma Association (ANZSA) Strategic Plan 2022-2024. This second strategic plan comes after successfully completing our Strategic Plan 2016-2021, which included 34 milestones.
The Strategic Plan 2022-2024 will continue to expand on the work we have embarked on that is driven by high-quality patient-centred clinical trials and research to improve patient survival rates and quality of life.
Download to read the full ANZSA Strategic Plan 2022-2024.
Quality Research and Clinical Care
Funding and Governance
Professional Education
Advocacy and Awareness
- To improve patient survival rates and outcomes
- To build a strong research capability
- To deepen the portfolio of high-quality patient-centred clinical trials
- To enable patient recruitment to clinical trials
- To contribute to the development of a universal and harmonised approach to sarcoma treatment and care
- To improve and expand data collection and analytics
- To develop a sarcoma registry to world-class standards
- To deepen and further diversify funding sources
- To encourage philanthropic activity
- To increase government and peer-reviewed funding to sarcoma and related tumour research projects
- To achieve a sustainable long-term funding position
- To lead the application of contemporary governance practice, implementation of the Strategic Plan and prudent oversight of risk management
- To attract, develop and retain the best talent to work in sarcoma
- To recognise ANZSA members contributing to high-quality sarcoma and related tumour research
- To foster the next generation of sarcoma clinicians and researchers
- To foster the next generation of sarcoma clinicians and researchers
- To establish a framework for sarcoma professional education
- To encourage, welcome and promote active contribution from the orthopaedic sarcoma surgeon community
- To leverage the relationship with ISOLS and other educational bodies
- To promote sarcoma and related tumour research and clinical care to the clinical community
- To promote sarcoma guidelines and clinical care standards to the clinical community
- To promote sarcoma and tumour related research to the broader community
- To raise ANZSA’s profile nationally and internationally
- To develop a closer engagement with the New Zealand sarcoma community
- To develop a closer relationship with the sarcoma orthopaedic surgeon community within ANZSA
- To cultivate influence internationally through the promotion of high-quality Australia and New Zealand sarcoma and tumour related research
- To be a strong public advocate for patients, survivors and their families
- To more purposefully advocate to government